Switch theme
Sign up to access all valuation multiples
Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.
2006
223
LTM Revenue $295M
LTM EBITDA -$8.2M
$494M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Aemetis has a last 12-month revenue (LTM) of $295M and a last 12-month EBITDA of -$8.2M.
In the most recent fiscal year, Aemetis achieved revenue of $268M and an EBITDA of -$49.8M.
Aemetis expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Aemetis valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $295M | XXX | $268M | XXX | XXX | XXX |
| Gross Profit | $9.2M | XXX | -$0.6M | XXX | XXX | XXX |
| Gross Margin | 3% | XXX | 0% | XXX | XXX | XXX |
| EBITDA | -$8.2M | XXX | -$49.8M | XXX | XXX | XXX |
| EBITDA Margin | -3% | XXX | -19% | XXX | XXX | XXX |
| EBIT | -$23.2M | XXX | -$40.4M | XXX | XXX | XXX |
| EBIT Margin | -8% | XXX | -15% | XXX | XXX | XXX |
| Net Profit | -$75.1M | XXX | -$87.5M | XXX | XXX | XXX |
| Net Margin | -25% | XXX | -33% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $337M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 31, 2025, Aemetis's stock price is $3.
Aemetis has current market cap of $158M, and EV of $494M.
See Aemetis trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $494M | $158M | XXX | XXX | XXX | XXX | $-1.44 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 31, 2025, Aemetis has market cap of $158M and EV of $494M.
Aemetis's trades at 1.8x EV/Revenue multiple, and -9.9x EV/EBITDA.
Equity research analysts estimate Aemetis's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Aemetis has a P/E ratio of -2.1x.
See valuation multiples for Aemetis and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $158M | XXX | $158M | XXX | XXX | XXX |
| EV (current) | $494M | XXX | $494M | XXX | XXX | XXX |
| EV/Revenue | 1.7x | XXX | 1.8x | XXX | XXX | XXX |
| EV/EBITDA | -60.1x | XXX | -9.9x | XXX | XXX | XXX |
| EV/EBIT | -21.3x | XXX | -12.2x | XXX | XXX | XXX |
| EV/Gross Profit | 53.9x | XXX | n/a | XXX | XXX | XXX |
| P/E | -2.1x | XXX | -1.8x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -9.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAemetis's last 12 month revenue growth is 66%
Aemetis's revenue per employee in the last FY averaged $1.2M, while opex per employee averaged $0.2M for the same period.
Aemetis's rule of 40 is 33% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Aemetis's rule of X is 161% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Aemetis and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 66% | XXX | 52% | XXX | XXX | XXX |
| EBITDA Margin | -3% | XXX | -19% | XXX | XXX | XXX |
| EBITDA Growth | -522% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | 33% | XXX | 47% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 161% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $1.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 15% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Borouge | XXX | XXX | XXX | XXX | XXX | XXX |
| Fertiglobe | XXX | XXX | XXX | XXX | XXX | XXX |
| Akzo Nobel | XXX | XXX | XXX | XXX | XXX | XXX |
| Avantium | XXX | XXX | XXX | XXX | XXX | XXX |
| DSM Firmenich | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Aemetis acquired XXX companies to date.
Last acquisition by Aemetis was XXXXXXXX, XXXXX XXXXX XXXXXX . Aemetis acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Aemetis founded? | Aemetis was founded in 2006. |
| Where is Aemetis headquartered? | Aemetis is headquartered in United States of America. |
| How many employees does Aemetis have? | As of today, Aemetis has 223 employees. |
| Who is the CEO of Aemetis? | Aemetis's CEO is Mr. Eric A. McAfee. |
| Is Aemetis publicy listed? | Yes, Aemetis is a public company listed on NAS. |
| What is the stock symbol of Aemetis? | Aemetis trades under AMTX ticker. |
| When did Aemetis go public? | Aemetis went public in 1990. |
| Who are competitors of Aemetis? | Similar companies to Aemetis include e.g. Borouge, Fertiglobe, Akzo Nobel, Avantium. |
| What is the current market cap of Aemetis? | Aemetis's current market cap is $158M |
| What is the current revenue of Aemetis? | Aemetis's last 12 months revenue is $295M. |
| What is the current revenue growth of Aemetis? | Aemetis revenue growth (NTM/LTM) is 66%. |
| What is the current EV/Revenue multiple of Aemetis? | Current revenue multiple of Aemetis is 1.7x. |
| Is Aemetis profitable? | Yes, Aemetis is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Aemetis? | Aemetis's last 12 months EBITDA is -$8.2M. |
| What is Aemetis's EBITDA margin? | Aemetis's last 12 months EBITDA margin is -3%. |
| What is the current EV/EBITDA multiple of Aemetis? | Current EBITDA multiple of Aemetis is -60.1x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
